Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

"Looking ahead, Arce “project[s] top-line AURORA results at the end of 2019 or early 2020, followed by NDA submittal likely by June 2020. Given voclosporin’s Fast Track designation, we expect the drug to be granted Priority Review (8 months from submittal), leading to a potential commercial launch in 1Q 2021"

And that grasshopper is the problem...